ClinicalTrials.govpublic full text
Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance
chronic hepatitis c, insulin resistance, hepatitis c; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886058
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.